Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

PHASE1CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

September 21, 2021

Study Completion Date

September 21, 2021

Conditions
Breast CarcinomaDigestive System NeoplasmMalignant Brain NeoplasmMalignant Central Nervous System NeoplasmMalignant Female Reproductive System NeoplasmMalignant Genitourinary System NeoplasmMalignant Head and Neck NeoplasmMalignant Musculoskeletal NeoplasmMalignant Solid NeoplasmMetastatic Malignant Neoplasm of Unknown PrimarySkin Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

OTHER

Genetic Counseling

Watch pre-test genetic counseling video

OTHER

Genetic Testing

Undergo genetic testing

OTHER

Survey Administration

Ancillary studies

Trial Locations (2)

85259

Mayo Clinic in Arizona, Scottsdale

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04456140 - Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study | Biotech Hunter | Biotech Hunter